# BPL-1357 Against H1N1 Influenza Virus Challenge

> **NCT07215858** · PHASE2 · RECRUITING · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 129 (estimated)

## Conditions studied

- Influenza
- Human

## Interventions

- **BIOLOGICAL:** BPL-1357 IM
- **BIOLOGICAL:** BPL-1357 IN
- **OTHER:** Placebo IM
- **OTHER:** Placebo IN

## Key facts

- **NCT ID:** NCT07215858
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-23
- **Primary completion:** 2028-03-01
- **Final completion:** 2028-03-01
- **Target enrollment:** 129 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07215858

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07215858, "BPL-1357 Against H1N1 Influenza Virus Challenge". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07215858. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*